Page last updated: 2024-10-27

gabapentin and Depression

gabapentin has been researched along with Depression in 30 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research Excerpts

ExcerptRelevanceReference
" Our goal was to compare the effects of gabapentin and pregabalin on improving sleep quality and depression among hemodialysis patients with PPN."9.17Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial. ( Atalay, H; Biyik, Z; Gaipov, A; Guney, F; Solak, Y; Turk, S, 2013)
"The purpose of this, open-label, non-comparative study, was to evaluate the efficacy on quality of life and the efficacy of gabapentin monotherapy in patients with chronic radiculopathy."9.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Gabapentin can relieve chronic pain and depression-like behavior in rats with chronic pain and depression, and promote neurogenesis of hippocampal dentate gyrus neurons."8.12Effect of gabapentin on neurogenesis in hippocampal dentate gyrus of adult rats with co-disease of chronic pain and depression. ( Jiang, X; Tan, Y; Yang, L; Zeng, W, 2022)
"Gabapentin is a commonly prescribed antiepileptic agent for seizures, which is also used for pain and addiction management."5.91Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition. ( Ali, G; Alkahramaan, YMSA; Arif, M; Gohar, A; Khan, MS; Rashid, U; Rauf, K; Sewell, RDE, 2023)
"Symptoms consistent with bruxism are a common chief complaint in dental practice."5.30Antidepressant-induced bruxism successfully treated with gabapentin. ( Brown, ES; Hong, SC, 1999)
" Our goal was to compare the effects of gabapentin and pregabalin on improving sleep quality and depression among hemodialysis patients with PPN."5.17Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial. ( Atalay, H; Biyik, Z; Gaipov, A; Guney, F; Solak, Y; Turk, S, 2013)
"The purpose of this, open-label, non-comparative study, was to evaluate the efficacy on quality of life and the efficacy of gabapentin monotherapy in patients with chronic radiculopathy."5.14Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. ( Deniz, O; Erdal, A; Gureser, G; Karatay, S; Senel, K; Ugur, M; Yildirim, K, 2009)
"Gabapentin can relieve chronic pain and depression-like behavior in rats with chronic pain and depression, and promote neurogenesis of hippocampal dentate gyrus neurons."4.12Effect of gabapentin on neurogenesis in hippocampal dentate gyrus of adult rats with co-disease of chronic pain and depression. ( Jiang, X; Tan, Y; Yang, L; Zeng, W, 2022)
"Based on clinical studies regarding the beneficial effect of gabapentin in depression, we aimed to evaluate the antidepressant-like properties of gabapentin in mice and also the participation of nitric oxide (NO)/cyclic guanosine monophosphate pathway in this effect."3.83Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test. ( Akhlaghipour, G; Ameli, S; Dehpour, A; Haj-Mirzaian, A; Kordjazy, N; Ostadhadi, S, 2016)
"Cocaine dependence is a major public health problem with no available robustly effective pharmacotherapy."2.79Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. ( Cargile, C; Chopra, MP; Guise, JB; Kosten, TR; Mancino, MJ; McGaugh, J; Oliveto, A; Sanders, N; Thostenson, J; Williams, DK, 2014)
"Gabapentin 2400 mg/day was given in case of treatment failure or if imipramine treatment was not possible."2.71Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion. ( Bach, FW; Jensen, TS; Rasmussen, PV; Sindrup, SH, 2004)
" This study examined the single-dose pharmacokinetic profiles of Li in 13 patients receiving placebo and then steady-state gabapentin (mean daily dose: 3,646."2.69Gabapentin does not alter single-dose lithium pharmacokinetics. ( Corá-Locatelli, G; Dunn, RT; Frye, MA; Grothe, D; Ketter, TA; Kimbrell, TA; Piscitelli, S; Post, RM; Vanderham, E, 1998)
"The most common risk factor for shingles and its potential sequela, PHN, is advanced age."2.42Post-herpetic neuralgia case study: optimizing pain control. ( Baron, R, 2004)
"The incidence of melanoma is rising rapidly, and the use of this regimen is becoming increasingly common."2.41Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. ( Everett, JR; Gadd, MA; Greenberg, DB; Haluska, FG; Jonasch, E; Mihm, MA; Ott, M; Ryan, BF; Sober, AJ; Tanabe, KK, 2000)
"Gabapentin is a commonly prescribed antiepileptic agent for seizures, which is also used for pain and addiction management."1.91Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition. ( Ali, G; Alkahramaan, YMSA; Arif, M; Gohar, A; Khan, MS; Rashid, U; Rauf, K; Sewell, RDE, 2023)
"Gabapentin treatment was initiated after baseline evaluation, and the RDD and visual analog scale (VAS) score were both evaluated regularly during the 2-week study period."1.72Rate-Dependent Depression: A Predictor of the Therapeutic Efficacy in Treating Painful Diabetic Peripheral Neuropathy. ( Calcutt, NA; Guan, Y; Lin, Z; Wang, Z; Xie, C; Zhou, X; Zhu, D; Zhu, Y, 2022)
"Many patients with chronic pain conditions suffer from depression."1.62Dynamic Change of Endocannabinoid Signaling in the Medial Prefrontal Cortex Controls the Development of Depression After Neuropathic Pain. ( Chao, D; Feng, Y; Hillard, CJ; Hogan, QH; Mecca, CM; Pan, B; Pawela, CP; Rodriguez-Garcia, DM; Segel, I; Yu, G; Zhang, Z, 2021)
"The analysis of the case of vulvodynia coexisting with depression."1.46Vulvodynia and depression - a case study. ( Derewianka-Polak, M; Dziwota, EA; Gerhant, A; Olajossy, M; Perzyńska-Starkiewicz, A, 2017)
"Intracranial stab wounds are low-velocity, penetrating injuries to the brain and fatality and outcome significantly depend on route, depth and location of cranial penetration."1.39Self-inflicted trans-oral intracranial stab wound. ( Han, ZA; Kim, JH; Kim, SW, 2013)
"Anxiety and depression are often also present."1.35Fibromyalgia: poorly understood; treatments are disappointing. ( , 2009)
"Symptoms consistent with bruxism are a common chief complaint in dental practice."1.30Antidepressant-induced bruxism successfully treated with gabapentin. ( Brown, ES; Hong, SC, 1999)

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (6.67)18.2507
2000's9 (30.00)29.6817
2010's14 (46.67)24.3611
2020's5 (16.67)2.80

Authors

AuthorsStudies
Zhou, X1
Zhu, Y1
Wang, Z1
Lin, Z1
Zhu, D1
Xie, C1
Calcutt, NA1
Guan, Y1
Zeng, W1
Tan, Y1
Yang, L1
Jiang, X1
Gohar, A1
Ali, G1
Rashid, U1
Rauf, K1
Arif, M1
Khan, MS1
Alkahramaan, YMSA1
Sewell, RDE1
Kim, J1
Lee, SH1
Kim, TH1
Mecca, CM1
Chao, D1
Yu, G1
Feng, Y1
Segel, I1
Zhang, Z1
Rodriguez-Garcia, DM1
Pawela, CP1
Hillard, CJ1
Hogan, QH1
Pan, B1
Gerhant, A1
Dziwota, EA1
Perzyńska-Starkiewicz, A1
Derewianka-Polak, M1
Olajossy, M1
Till, SR1
As-Sanie, S1
Schrepf, A1
Kim, SW1
Kim, JH1
Han, ZA1
Marchiori, ÉC1
Barber, JS1
Williams, WB1
Bui, PQ1
O'Ryan, FS1
Mah, L1
Hart, M1
Mancino, MJ1
McGaugh, J1
Chopra, MP1
Guise, JB1
Cargile, C1
Williams, DK1
Thostenson, J1
Kosten, TR1
Sanders, N1
Oliveto, A1
Mehta, S1
McIntyre, A1
Dijkers, M1
Loh, E1
Teasell, RW1
Kilic, FS1
Ismailoglu, S1
Kaygisiz, B1
Oner, S1
Evrensel, A1
Ünsalver, BÖ1
Lubelski, D1
Thompson, NR1
Agrawal, B1
Abdullah, KG1
Alvin, MD1
Khalaf, T1
Mazanec, DJ1
Benzel, EC1
Mroz, TE1
Krishnaney, AA1
Ostadhadi, S1
Kordjazy, N1
Haj-Mirzaian, A1
Ameli, S1
Akhlaghipour, G1
Dehpour, A1
Czubak, A1
Nowakowska, E1
Kus, K1
Sadowski, C1
Matschay, A1
Yildirim, K1
Deniz, O1
Gureser, G1
Karatay, S1
Ugur, M1
Erdal, A1
Senel, K1
Kaufman, KR1
Struck, PJ1
Valente, MM1
Bortolotto, V1
Cuccurazzu, B1
Ubezio, F1
Meneghini, V1
Francese, MT1
Canonico, PL1
Grilli, M1
Biyik, Z1
Solak, Y1
Atalay, H1
Gaipov, A1
Guney, F1
Turk, S1
Carter, AC1
Nicholas, JJ1
Baron, R1
Rasmussen, PV1
Sindrup, SH1
Jensen, TS1
Bach, FW1
Rejas, J1
Ribera, MV1
Ruiz, M1
Masrramón, X1
Frye, MA1
Kimbrell, TA1
Dunn, RT1
Piscitelli, S1
Grothe, D1
Vanderham, E1
Corá-Locatelli, G1
Post, RM1
Ketter, TA1
Brown, ES1
Hong, SC1
Greenberg, DB1
Jonasch, E1
Gadd, MA1
Ryan, BF1
Everett, JR1
Sober, AJ1
Mihm, MA1
Tanabe, KK1
Ott, M1
Haluska, FG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Efficacy of Gabapentine and Splint Therapy in Bruxers: a Randomized Clinical Trial[NCT01255878]20 participants (Actual)Interventional2010-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for gabapentin and Depression

ArticleYear
Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment.
    Clinical obstetrics and gynecology, 2019, Volume: 62, Issue:1

    Topics: Antidepressive Agents, Tricyclic; Anxiety; Catastrophization; Chronic Pain; Cognitive Behavioral The

2019
Gabapentin withdrawal: case report in an older adult and review of the literature.
    Journal of the American Geriatrics Society, 2013, Volume: 61, Issue:9

    Topics: Aged; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Depression; Female; Gabapentin; gamm

2013
Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis.
    Archives of physical medicine and rehabilitation, 2014, Volume: 95, Issue:11

    Topics: Amines; Analgesics; Anxiety; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Depression; Gaba

2014
Post-herpetic neuralgia case study: optimizing pain control.
    European journal of neurology, 2004, Volume: 11 Suppl 1

    Topics: Acetates; Aged; Amines; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Cyclohexanecarb

2004
Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes.
    Cancer, 2000, Jul-15, Volume: 89, Issue:2

    Topics: Acetates; Adult; Amines; Anti-Anxiety Agents; Antimanic Agents; Antineoplastic Agents; Bipolar Disor

2000

Trials

6 trials available for gabapentin and Depression

ArticleYear
Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
    Journal of clinical psychopharmacology, 2014, Volume: 34, Issue:2

    Topics: Adult; Amines; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; C

2014
Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality.
    Journal of back and musculoskeletal rehabilitation, 2009, Volume: 22, Issue:1

    Topics: Administration, Oral; Adult; Amines; Anticonvulsants; Chronic Disease; Cyclohexanecarboxylic Acids;

2009
Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial.
    International urology and nephrology, 2013, Volume: 45, Issue:3

    Topics: Amines; Anti-Anxiety Agents; Calcium Channel Blockers; Cross-Over Studies; Cyclohexanecarboxylic Aci

2013
Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion.
    European journal of neurology, 2004, Volume: 11, Issue:8

    Topics: Acetates; Adult; Aged; Amines; Chi-Square Distribution; Cyclohexanecarboxylic Acids; Depression; Dos

2004
Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain.
    European journal of pain (London, England), 2007, Volume: 11, Issue:3

    Topics: Adult; Aged; Amines; Analgesics; Anxiety; Cyclohexanecarboxylic Acids; Depression; Disability Evalua

2007
Gabapentin does not alter single-dose lithium pharmacokinetics.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:6

    Topics: Acetates; Amines; Antimanic Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids; Depression; Doubl

1998

Other Studies

19 other studies available for gabapentin and Depression

ArticleYear
Rate-Dependent Depression: A Predictor of the Therapeutic Efficacy in Treating Painful Diabetic Peripheral Neuropathy.
    Diabetes, 2022, 06-01, Volume: 71, Issue:6

    Topics: Depression; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Gabapentin; Humans; Pain

2022
Effect of gabapentin on neurogenesis in hippocampal dentate gyrus of adult rats with co-disease of chronic pain and depression.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2022, Jul-28, Volume: 47, Issue:7

    Topics: Animals; Brain-Derived Neurotrophic Factor; Chronic Pain; Dentate Gyrus; Depression; Gabapentin; Hip

2022
Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition.
    Drug design, development and therapy, 2023, Volume: 17

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Ascorbic Acid; Behavior, Animal; Cogni

2023
Improvement of sleep quality after treatment in patients with lumbar spinal stenosis: a prospective comparative study between conservative versus surgical treatment.
    Scientific reports, 2020, 08-24, Volume: 10, Issue:1

    Topics: Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Conservative Treatment; Decompres

2020
Dynamic Change of Endocannabinoid Signaling in the Medial Prefrontal Cortex Controls the Development of Depression After Neuropathic Pain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021, 09-01, Volume: 41, Issue:35

    Topics: Animals; Brain Mapping; Chronic Pain; Depression; Endocannabinoids; Feeding Behavior; Female; GABAer

2021
Vulvodynia and depression - a case study.
    Psychiatria polska, 2017, Oct-29, Volume: 51, Issue:5

    Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Depression; Female; Gabapentin; gamma-Aminobutyric

2017
Self-inflicted trans-oral intracranial stab wound.
    Brain injury, 2013, Volume: 27, Issue:10

    Topics: Amines; Analgesics; Antidepressive Agents; Brain Injuries; Cerebellum; Citalopram; Cyclohexanecarbox

2013
Neuropathic pain following sagittal split ramus osteotomy of the mandible: prevalence, risk factors, and clinical course.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2013, Volume: 71, Issue:12

    Topics: Adult; Age Factors; Amines; Anticonvulsants; Antidepressive Agents, Tricyclic; Cohort Studies; Cyclo

2013
Effects of single and combined gabapentin use in elevated plus maze and forced swimming tests.
    Acta neuropsychiatrica, 2014, Volume: 26, Issue:5

    Topics: Amines; Amitriptyline; Animals; Anticonvulsants; Anxiety; Cyclohexanecarboxylic Acids; Depression; D

2014
Psychotic and depressive symptoms after gabapentin treatment.
    International journal of psychiatry in medicine, 2015, Volume: 49, Issue:4

    Topics: Amines; Cyclohexanecarboxylic Acids; Depression; Excitatory Amino Acid Antagonists; Female; Gabapent

2015
Prediction of quality of life improvements in patients with lumbar stenosis following use of membrane stabilizing agents.
    Clinical neurology and neurosurgery, 2015, Volume: 139

    Topics: Aged; Aged, 80 and over; Amines; Calcium Channel Blockers; Comorbidity; Cyclohexanecarboxylic Acids;

2015
Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:4

    Topics: Amines; Animals; Antidepressive Agents; Behavior, Animal; Cyclic GMP; Cyclohexanecarboxylic Acids; D

2016
Effect of gabapentin on cognitive processes in rats not exposed and exposed to tobacco smoke during fetal life.
    Human & experimental toxicology, 2008, Volume: 27, Issue:12

    Topics: Amines; Animals; Anticonvulsants; Antidepressive Agents; Behavior, Animal; Cognition; Cyclohexanecar

2008
Fibromyalgia: poorly understood; treatments are disappointing.
    Prescrire international, 2009, Volume: 18, Issue:102

    Topics: Acetaminophen; Acupuncture Therapy; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Ant

2009
Gabapentin-induced sexual dysfunction.
    Epilepsy & behavior : E&B, 2011, Volume: 21, Issue:3

    Topics: Adult; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Depression; Gabapentin; gamma-Amino

2011
α2δ ligands act as positive modulators of adult hippocampal neurogenesis and prevent depression-like behavior induced by chronic restraint stress.
    Molecular pharmacology, 2012, Volume: 82, Issue:2

    Topics: Amines; Animals; Calcium Channels; Cell Differentiation; Cyclohexanecarboxylic Acids; Depression; Ga

2012
The importance of the complete history in the discovery of a potential suicide: a case report.
    Archives of physical medicine and rehabilitation, 2003, Volume: 84, Issue:3

    Topics: Acetates; Amines; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Cyclohexanecarboxy

2003
[Unclear chronic aches. Often depression plays a part therein].
    MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2

    Topics: Acetates; Amines; Analgesics, Opioid; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age

2003
Antidepressant-induced bruxism successfully treated with gabapentin.
    Journal of the American Dental Association (1939), 1999, Volume: 130, Issue:10

    Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; B

1999